Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare Gridelli

Showing results (71-80 of 357) with videos related to

Pageof 36
Sort By:
Critical Reviews in Oncology/Hematology|April 22, 2008
The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancerCesare Gridelli, Antonio Rossi, Paolo Maione
Expert Opinion on Biological Therapy|March 10, 2017
The role of checkpoint inhibitors immunotherapy in advanced non-small cell lung cancer in the elderlyAssunta Sgambato, Francesca Casaluce, Cesare Gridelli
Oncogene|October 7, 2003
Treatment of non-small-cell lung cancer: state of the art and development of new biologic agentsCesare Gridelli, Antonio Rossi, Paolo Maione
Tumori|May 7, 2002
Pharmacokinetics of Navelbine oral in elderly patientsChristian Puozzo, Cesare Gridelli, Michel Jaworski
Journal of the National Cancer Institute|July 4, 2002
Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trialFrancesco Perrone, Ciro Gallo, Cesare Gridelli
Current Opinion in Oncology|February 3, 2007
Combined targeted therapies in non-small cell lung cancer: a winner strategy?Tina Cascone, Cesare Gridelli, Fortunato Ciardiello
Clinical Lung Cancer|June 24, 2014
Fractionated scheme of oral vinorelbine as single-agent therapy or in combination with cisplatin concomitantly with thoracic radiotherapy in stage III non-small-cell lung cancer: dose-escalation phase I trialMaciej Krzakowski, Christel Lucas, Cesare Gridelli
Current Clinical Pharmacology|August 11, 2019
The New Immunotherapy Combinations in the Treatment of Advanced Non-Small Cell Lung Cancer: Reality and PerspectivesDanilo Rocco, Luigi D Gravara, Cesare Gridelli
The Oncologist|August 4, 2007
Multidisciplinary treatment of malignant pleural mesotheliomaGiovanni Luca Ceresoli, Cesare Gridelli, Armando Santoro
The Journal of Supportive Oncology|October 13, 2005
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting in elderly patientsMatti S Aapro, Alberto Macciocchi, Cesare Gridelli
Pageof 36

Showing results (71-80 of 357) with videos related to

Sort By:
Pageof 36
Critical Reviews in Oncology/Hematology|April 22, 2008
The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancerCesare Gridelli, Antonio Rossi, Paolo Maione
Expert Opinion on Biological Therapy|March 10, 2017
The role of checkpoint inhibitors immunotherapy in advanced non-small cell lung cancer in the elderlyAssunta Sgambato, Francesca Casaluce, Cesare Gridelli
Oncogene|October 7, 2003
Treatment of non-small-cell lung cancer: state of the art and development of new biologic agentsCesare Gridelli, Antonio Rossi, Paolo Maione
Tumori|May 7, 2002
Pharmacokinetics of Navelbine oral in elderly patientsChristian Puozzo, Cesare Gridelli, Michel Jaworski
Journal of the National Cancer Institute|July 4, 2002
Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trialFrancesco Perrone, Ciro Gallo, Cesare Gridelli
Current Opinion in Oncology|February 3, 2007
Combined targeted therapies in non-small cell lung cancer: a winner strategy?Tina Cascone, Cesare Gridelli, Fortunato Ciardiello
Clinical Lung Cancer|June 24, 2014
Fractionated scheme of oral vinorelbine as single-agent therapy or in combination with cisplatin concomitantly with thoracic radiotherapy in stage III non-small-cell lung cancer: dose-escalation phase I trialMaciej Krzakowski, Christel Lucas, Cesare Gridelli
Current Clinical Pharmacology|August 11, 2019
The New Immunotherapy Combinations in the Treatment of Advanced Non-Small Cell Lung Cancer: Reality and PerspectivesDanilo Rocco, Luigi D Gravara, Cesare Gridelli
The Oncologist|August 4, 2007
Multidisciplinary treatment of malignant pleural mesotheliomaGiovanni Luca Ceresoli, Cesare Gridelli, Armando Santoro
The Journal of Supportive Oncology|October 13, 2005
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting in elderly patientsMatti S Aapro, Alberto Macciocchi, Cesare Gridelli
Pageof 36